Encompass Health EBIT 2010-2024 | EHC

Encompass Health EBIT for the quarter ending December 31, 2024 was $0.232B, a 22.33% increase year-over-year.

  • Encompass Health 2024 EBIT was 0.865B, a 18.13% increase from 2023.
  • Encompass Health 2023 EBIT was 0.732B, a 16.12% increase from 2022.
  • Encompass Health 2022 EBIT was 0.63B, a 4.28% decline from 2021.

EBIT can be defined as earnings before interest and taxes.

Encompass Health EBIT 2010-2024 | EHC

  • Encompass Health 2024 EBIT was 0.865B, a 18.13% increase from 2023.
  • Encompass Health 2023 EBIT was 0.732B, a 16.12% increase from 2022.
  • Encompass Health 2022 EBIT was 0.63B, a 4.28% decline from 2021.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Fresenius SE (FSNUY)$21.5B
Quest Diagnostics (DGX)$19.2B
DaVita (DVA)$12.4B
Chemed (CHE)$8.4B
Elanco Animal Health (ELAN)$5.6B
Option Care Health (OPCH)$5.5B
RadNet (RDNT)$4.8B
LifeStance Health (LFST)$3.1B
Amedisys (AMED)$3B
Astrana Health (ASTH)$2.2B
Addus HomeCare (ADUS)$2.1B
U.S Physical Therapy (USPH)$1.3B
Aveanna Healthcare Holdings (AVAH)$968M
Pennant (PNTG)$927M
Atai Life Sciences (ATAI)$351M
Bioqual (BIOQ)$54M
Daxor (DXR)$35M
Ontrak (OTRK)$7M
MEDIROM Healthcare Technologies (MRM)$4M
IMAC Holdings (BACK)$1M
Psychemedics (PMD)$0M